Keenova Therapeutics plc Financing Receivable, after Allowance for Credit Loss, Current
Keenova Therapeutics plc had Financing Receivable, after Allowance for Credit Loss, Current of $0 as of 2018-12-28, per its 10-K filed 2019-02-26.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:NotesAndLoansReceivableNetCurrent · last filed 2019-02-26
- 2018-12-28: Financing Receivable, after Allowance for Credit Loss, Current $0.00.
- 2018-09-28: Financing Receivable, after Allowance for Credit Loss, Current $0.00.
- 2018-06-29: Financing Receivable, after Allowance for Credit Loss, Current $0.00.
- 2018-03-30: Financing Receivable, after Allowance for Credit Loss, Current $0.00.
| Period end | Financing Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2018-12-28 | $0.00 10-K · filed 2019-02-26 |
| 2018-09-28 | $0.00 10-Q · filed 2018-11-06 |
| 2018-06-29 | $0.00 10-Q · filed 2018-08-07 |
| 2018-03-30 | $0.00 10-Q · filed 2018-05-08 |
| 2017-12-29 | $154.00M 10-K · filed 2019-02-26 |
| 2017-09-29 | $154.00M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $154.00M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $154.00M 10-Q · filed 2017-05-08 |
| 2016-12-30 | $0.00 10-K · filed 2018-02-27 |